Science for Resilience –Learnings from the Pandemic

Conference, May 23 – May 24, 2022

In the third year of being shaken by the novel SARS-CoV-2 virus and its variants, it is time for a critical assessment and to plan looking ahead. The interdisciplinary “Science for Resilience” Conference in May 23-24 2022 was set up to discuss the following questions: what can we learn from the way the pandemic has been handled so far? And how can newly obtained knowledge be best applied to inform evidence-based decisions? The conference was conceived of a group of high-level researchers with different disciplinary backgrounds, all organized under the umbrella of the Future Operations Platform (FUOP). It was organized by IHS and supported by different research organizations and enterprises. Its ambition to promote an open and interdisciplinary culture of debate in Austria was fully achieved, not least because it revolved around an updated FUOP paper on different scenarios for fall 2022 that was also widely reported in Austrian news media. This website documents the various contributions that were given in seven panels during the two-day event at the Institute of Molecular Biology (IMBA).


Conference Program

Monday, 23.5.2022

9:00-09:15  Opening and Welcome

  • Antonella Mei-Pochtler (Think Austria, Federal Chancellery, Republic of Austria)
  • Ulrich Elling (IMBA)
  • Herwig Ostermann (Austrian National Public Health Institute)
  • Thomas König (Institute for Advanced Studies – IHS)

09:15-11:00  How can the right data be made available to the right people at the right time – in order to facilitate smart and timely decision making?  (Thematic Session 1)

Chair: Michael Stampfer (WWTF)

11:30-13:00 How to build resilient health systems? (Thematic Session 2)

Chair: Andrea E. Schmidt (Austrian National Public Health Institute)

14:30-16:00  What scenarios can we expect for the Fall of 2022 and in the coming years, and how shall we prepare for it?  (Thematic Session 3)

Chair: Arne Bathke (University of Salzburg)

16:30-18:00  How does SARS-CoV 2 evolve and what are implications for treatment and immunity? (Thematic Session 4)

  • Janine Kimpel (Medical University of Innsbruck) – Analysis of Variants
  • Richard Peabody (WHO)  (online) 
  • Trevor Bedford (Fred Hutchinson Cancer Research Center, Nextstrain) – Continuing SARS-CoV-2 evolution and diversification post-Omicron (online)

Chair: Andreas Bergthaler (Medical University of Vienna, CeMM)

18:00-19:30  Panel Discussion 1 – Vulnerable Populationen: Psychosoziale Bedingungen, Diversität und Inklusion (in German)

  • Adrian Graf (Gymnasium BG18 Klostergasse)
  • Heinz Katschnig (Medical University of Vienna)
  • Birgit Meinhard (Interest Group Caring Relatives) 
  • Sigrid Pilz (Patient advocate, City of Vienna) 
  • Eva Potura (Second Victim)
  • Martin Schenk (Diakonie)

Chair: Tanja Stamm (Medical University of Vienna and Ludwig Boltzmann Gesellschaft)


Tuesday, 24.5.2022

09:00-10:30  What are the best approaches to increase trust, to improve communication, and to reduce polarization? (Thematic Session 5)

Chair: Christian Korunka (University of Vienna)

11:00-12:30 How do science and public policy interact in times of crisis?  (Thematic Session 6)

Chair: Thomas König (Institute for Advanced Studies - IHS)

12:30-14:00  Press Conference

14:00-15:30  How do we make daycare and schools "safe" in spite of the pandemic? – Panel Discussion (Thematic Session 7)

Chair: Barbara Schober (University of Vienna)

16:00-17:30 - Panel Discussion 2 – Lessons Learned (in German)

  • Ingomar Gutman (High-risk patient, University of Vienna, UMC Groningen)
  • Katharina Reich (Austrian Federal Ministry of Health)
  • Thomas Starlinger (Office of the Austrian President)
  • Andrea E. Schmidt (Austrian National Public Health Institute)
  • Dorothee Van Laer (Medical University of Innsbruck) 
  • Elke Ziegler (ORF)

Chair: Andreas Bergthaler (Medical University Vienna, CeMM)

18:00  Conclusions/Closing and Social Event


Arne Bathke (Paris Lodron University Salzburg), Andreas Bergthaler (MedUni Vienna, CeMM), Ulrich Elling (Institute of Molecular Biotechnology), Anita Gottlob (Austrian National Public Health Institute), Helmut Hönigmayer (Institute for Advanced Studies – IHS), Thomas König (Institute for Advanced Studies – IHS), Claudia Royc (Institute for Advanced Studies – IHS), Andrea E. Schmidt (Austrian National Public Health Institute)

Please register at event(at)

You can also participate online over Zoom:

The event is taking place at the Lecture Hall of IMP at Vienna Biocenter, in coordination with IHS, IMBA, Gesundheit Österreich. You can also participate over Zoom, please note that the event will be recorded.

We thank our supporters: Verbund, WWTF and IMP.